Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.33)
# 3,022
Out of 5,182 analysts
78
Total ratings
49.35%
Success rate
21.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $45 | $3.03 | +1,385.15% | 6 | Apr 27, 2026 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $28.56 | +250.14% | 4 | Apr 20, 2026 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $50 | $24.27 | +106.02% | 3 | Apr 2, 2026 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $27.52 | +81.69% | 3 | Mar 26, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $510 | $308.51 | +65.31% | 5 | Mar 25, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $100 | $73.60 | +35.87% | 6 | Mar 25, 2026 | |
| ATAI AtaiBeckley | Reiterates: Buy | $25 | $4.34 | +476.04% | 3 | Mar 17, 2026 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $25 | $3.76 | +564.89% | 3 | Mar 17, 2026 | |
| ALT Altimmune | Maintains: Buy | $12 → $25 | $2.80 | +792.86% | 3 | Mar 16, 2026 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $7.82 | +859.08% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $6.43 | +677.60% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $17.90 | +291.06% | 7 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $0.35 | +1,334.72% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $145 | $90.24 | +60.68% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $10.64 | +87.97% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $28.71 | +108.99% | 4 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $95 | $5.40 | +1,659.26% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $70 | $20.98 | +233.65% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $70 | $19.60 | +257.23% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $70 | $8.89 | +687.40% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $31.05 | +77.13% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.21 | +4,661.90% | 2 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.45 | +589.66% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.97 | +932.31% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.46 | +584.93% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $29.17 | +174.30% | 2 | Oct 10, 2025 |
NRx Pharmaceuticals
Apr 27, 2026
Reiterates: Buy
Price Target: $45
Current: $3.03
Upside: +1,385.15%
Immunocore Holdings
Apr 20, 2026
Reiterates: Buy
Price Target: $100
Current: $28.56
Upside: +250.14%
Alto Neuroscience
Apr 2, 2026
Reiterates: Buy
Price Target: $50
Current: $24.27
Upside: +106.02%
Assembly Biosciences
Mar 26, 2026
Reiterates: Buy
Price Target: $50
Current: $27.52
Upside: +81.69%
Alnylam Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $510
Current: $308.51
Upside: +65.31%
Arrowhead Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $100
Current: $73.60
Upside: +35.87%
AtaiBeckley
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $4.34
Upside: +476.04%
Voyager Therapeutics
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.76
Upside: +564.89%
Altimmune
Mar 16, 2026
Maintains: Buy
Price Target: $12 → $25
Current: $2.80
Upside: +792.86%
Silence Therapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $75
Current: $7.82
Upside: +859.08%
Mar 11, 2026
Reiterates: Buy
Price Target: $50
Current: $6.43
Upside: +677.60%
Mar 10, 2026
Reiterates: Buy
Price Target: $70
Current: $17.90
Upside: +291.06%
Mar 6, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $0.35
Upside: +1,334.72%
Mar 4, 2026
Maintains: Buy
Price Target: $115 → $145
Current: $90.24
Upside: +60.68%
Mar 4, 2026
Maintains: Buy
Price Target: $15 → $20
Current: $10.64
Upside: +87.97%
Mar 3, 2026
Reiterates: Buy
Price Target: $60
Current: $28.71
Upside: +108.99%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $95
Current: $5.40
Upside: +1,659.26%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $70
Current: $20.98
Upside: +233.65%
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $70
Current: $19.60
Upside: +257.23%
Mar 2, 2026
Maintains: Buy
Price Target: $40 → $70
Current: $8.89
Upside: +687.40%
Feb 25, 2026
Reiterates: Buy
Price Target: $55
Current: $31.05
Upside: +77.13%
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.21
Upside: +4,661.90%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.97
Upside: +932.31%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.46
Upside: +584.93%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $29.17
Upside: +174.30%